PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Penumbra, Inc. (PEN)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US70975L1070

CUSIP

70975L107

Sector

Healthcare

IPO Date

Sep 18, 2015

Highlights

Market Cap

$9.50B

EPS (TTM)

$0.87

PE Ratio

284.54

PEG Ratio

-62.27

Total Revenue (TTM)

$1.16B

Gross Profit (TTM)

$726.29M

EBITDA (TTM)

$33.77M

Year Range

$148.00 - $277.34

Target Price

$254.60

Short %

6.83%

Short Ratio

4.74

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
PEN vs. ELF PEN vs. MEDP PEN vs. PODD PEN vs. VOO PEN vs. SPY PEN vs. LLY
Popular comparisons:
PEN vs. ELF PEN vs. MEDP PEN vs. PODD PEN vs. VOO PEN vs. SPY PEN vs. LLY

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Penumbra, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-10.00%0.00%10.00%20.00%30.00%40.00%JulyAugustSeptemberOctoberNovemberDecember
36.16%
7.29%
PEN (Penumbra, Inc.)
Benchmark (^GSPC)

Returns By Period

Penumbra, Inc. had a return of -5.03% year-to-date (YTD) and -5.23% in the last 12 months.


PEN

YTD

-5.03%

1M

-0.66%

6M

35.72%

1Y

-5.23%

5Y*

8.42%

10Y*

N/A

^GSPC (Benchmark)

YTD

23.11%

1M

-0.36%

6M

7.02%

1Y

23.15%

5Y*

12.80%

10Y*

11.01%

Monthly Returns

The table below presents the monthly returns of PEN, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20240.26%-6.85%-5.00%-11.97%-3.56%-5.01%-7.16%21.08%-3.96%17.79%6.66%-5.03%
202312.56%3.83%7.19%1.95%8.17%11.95%-11.83%-12.81%-8.54%-20.98%16.19%13.26%13.07%
2022-21.34%-1.89%0.18%-22.32%-14.86%-15.25%11.93%17.79%15.49%-9.56%22.18%6.18%-22.57%
202149.19%8.94%-4.87%13.09%-18.59%10.02%-2.86%3.28%-3.07%3.77%-11.17%16.96%64.18%
20206.81%-5.47%-2.73%9.91%-2.76%3.71%24.10%-5.75%-7.06%34.29%-14.99%-21.14%6.53%
201919.08%-8.14%9.98%-8.51%6.10%12.12%4.75%-13.16%-7.60%15.97%13.43%-7.15%34.43%
20185.84%8.63%6.89%7.52%29.39%-14.14%2.97%-2.39%7.81%-9.15%2.37%-12.23%29.86%
201712.15%7.34%8.66%2.40%-3.04%5.91%-6.95%5.33%5.00%11.35%4.72%-10.64%47.49%
2016-20.46%8.93%-1.33%18.48%-3.14%12.71%14.81%3.29%7.70%-13.21%-6.14%3.07%18.57%
2015-2.91%-7.66%35.89%6.94%30.29%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of PEN is 41, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of PEN is 4141
Overall Rank
The Sharpe Ratio Rank of PEN is 4343
Sharpe Ratio Rank
The Sortino Ratio Rank of PEN is 3737
Sortino Ratio Rank
The Omega Ratio Rank of PEN is 3737
Omega Ratio Rank
The Calmar Ratio Rank of PEN is 4444
Calmar Ratio Rank
The Martin Ratio Rank of PEN is 4545
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Penumbra, Inc. (PEN) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for PEN, currently valued at -0.09, compared to the broader market-4.00-2.000.002.00-0.091.90
The chart of Sortino ratio for PEN, currently valued at 0.15, compared to the broader market-4.00-2.000.002.004.000.152.54
The chart of Omega ratio for PEN, currently valued at 1.02, compared to the broader market0.501.001.502.001.021.35
The chart of Calmar ratio for PEN, currently valued at -0.07, compared to the broader market0.002.004.006.00-0.072.81
The chart of Martin ratio for PEN, currently valued at -0.15, compared to the broader market0.0010.0020.00-0.1512.39
PEN
^GSPC

The current Penumbra, Inc. Sharpe ratio is -0.09. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Penumbra, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00JulyAugustSeptemberOctoberNovemberDecember
-0.09
1.90
PEN (Penumbra, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Penumbra, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-30.56%
-3.58%
PEN (Penumbra, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Penumbra, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Penumbra, Inc. was 62.64%, occurring on Jun 16, 2022. Recovery took 224 trading sessions.

The current Penumbra, Inc. drawdown is 30.56%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-62.64%Apr 29, 2021287Jun 16, 2022224May 9, 2023511
-52.44%Jul 3, 2023277Aug 7, 2024
-35.86%Nov 13, 202023Dec 16, 202036Feb 9, 202159
-35.83%Feb 20, 202023Mar 23, 202074Jul 8, 202097
-31.65%Jun 7, 2018139Dec 24, 2018118Jun 14, 2019257

Volatility

Volatility Chart

The current Penumbra, Inc. volatility is 8.69%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%JulyAugustSeptemberOctoberNovemberDecember
8.69%
3.64%
PEN (Penumbra, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Penumbra, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Valuation

The Valuation section provides an assessment of the market value of Penumbra, Inc. compared to its peers in the Medical Devices industry.


PE Ratio
50.0100.0150.0200.0284.5
The chart displays the price to earnings (P/E) ratio for PEN in comparison to other companies of the Medical Devices industry. Currently, PEN has a PE value of 284.5. This PE ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.
PEG Ratio
-60.0-40.0-20.00.020.040.060.080.0-62.3
The chart displays the price to earnings to growth (PEG) ratio for PEN in comparison to other companies of the Medical Devices industry. Currently, PEN has a PEG value of -62.3. This PEG value is considered to be low compared to the rest of the industry.

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Penumbra, Inc..


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab